This could explain why tirzepatide (which stimulates the GIP pathway in addition to GLP -1) can be administered at higher doses than semaglutide (which only stimulates GLP-1), without amplifying the side effects typical of GLP-1 agonists (nausea, vomiting)
Age below 50 vs 50 years or older served as proxies for premenopausal and postmenopausal status, respectively, with a sensitivity analysis conducted to assess age and menopausal confounding
[PMID: 17478491] PubMed record related to this compound for laboratory literature review
Indications now include cardiovascular risk reduction, obstructive sleep apnea and diabetes management, and emerging evidence supports efficacy for heart failure and chronic kidney disease
It may help to increase the breakdown of fat in the body and improve the use of fat as an energy source
Even light weights, resistance bands, or body-weight workouts help